Response to crizotinib in a lung adenocarcinoma patient harboring a novel SLC34A2-ROS1 fusion variant.
about
Response to crizotinib in a lung adenocarcinoma patient harboring a novel SLC34A2-ROS1 fusion variant.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Response to crizotinib in a lu ...... l SLC34A2-ROS1 fusion variant.
@en
type
label
Response to crizotinib in a lu ...... l SLC34A2-ROS1 fusion variant.
@en
prefLabel
Response to crizotinib in a lu ...... l SLC34A2-ROS1 fusion variant.
@en
P2093
P2860
P356
P1476
Response to crizotinib in a lu ...... l SLC34A2-ROS1 fusion variant.
@en
P2093
Haifeng Sun
Xiaomin Yang
Xuwei Wang
Zhangjun Song
Zheng Zhao
P2860
P304
P356
10.2147/OTT.S136297
P407
P577
2017-08-21T00:00:00Z